An extremely important part of the development of new products are the phases of Research and Development. These steps define and support the company strategy to enable our researchers to get special and innovative products, most of the time, unique in the market.
Our R&D+i department is divided into three working areas:
In Area I, developed Monoclonal Antibodies.
Area II is responsible for new IMMUNOCHROMATOGRAPHIC products.
And Area III is devoted to MOLECULAR DIAGNOSTIC products and Recombinant Antigens.